Hemostatic Drug Info
Search the site
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
Unexpected bleeding disorders: Algorithm for approach to therapy.
Inhibitor antibodies to factor VIII and factor IX: management.
New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.
© Copyright 2002-2018 ~
All rights reserved.